Debate: Is the FDA’s review process for GE animals fit for purpose?

To explore whether the regulatory process in question is fit for purpose, the Food & Drug Law Institute’s Food and Drug Policy Forum has published papers by those for and against GE animals, using AquaBounty Technologies’ experiences as a case study.

(AquaBounty  is seeking to gain approval for its genetically engineered AquAdvantage Atlantic salmon, which includes a gene from the faster-growing Pacific Chinook salmon enabling it to reach maturity twice as quickly as standard Atlantic salmon.)

In the red corner is Tim Schwab, senior researcher at anti-GM lobby group Food & Water Watch, who has penned the article: ‘Is FDA Ready to Regulate the World’s First Biotech Food Animal?’ (spoiler alert – he thinks ‘NO’). In the blue corner are Dr Alison L. Van Eenennaam, Dr William M. Muir, and Dr Eric M. Hallerman*, who have penned the response: ‘Is Unaccountable Regulatory Delay and Political Interference Undermining the FDA and Hurting American Competitiveness?’ (spoiler alert – they think ‘YES’)

Read the full story here:  GE salmon… Is the FDA’s review process for genetically engineered animals fit for purpose?


Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend